novo nordisk glp-1 receptor agonist weight management diabetes treatments The Landscape Of Agonists In And Obesity Treatment Novo Nordisk, Eli Lilly Slip

Di Meco A, Curtis ME, Lauretti E, Pratico D

Influence of culinary skills on ultraprocessed food consumption and Mediterranean diet adherence: an integrative review

Leipold G, Tth R, Hrsfalvi P, Lczi L, Trk M, Keszthelyi A, et al

MI and Stroke both contribute to 75% of death in type 2 diabetic patients

mTOR signaling in aging and neurodegeneration: at the crossroad between metabolism dysfunction and impairment of autophagy

The BCPNN analysis further validated these findings, demonstrating that female patients had higher risks of long-term treatment-related adverse reactions, whereas male patients experienced more acute adverse events in the short term